Drug intelligence / Profile preview

(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the quinazoline class of organic compounds. It features a hexahydroquinazoline core substituted with a methyl(3,4,5-trimethoxyphenyl)aminomethyl group and two amino groups at positions 2 and 4. The molecule has defined stereochemistry at positions (2R) and (6S). It is listed as an experimental drug in chemical databases but does not have an assigned therapeutic indication or known mechanism of action in humans. Its structure suggests potential for biological activity through interactions typical of quinazolines—such as kinase inhibition—but no specific pharmacological target or clinical use has been established.[1][9][8]

Other names
(2R)-6-[[methyl-(3,4,5-trimethoxyphenyl)amino]methyl]-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine2R6S 6-methyl(3 4 5-trimethoxyphenyl)aminomethyl 1 2 5 6 7 8 hexahydroquinazoline24diamine(2r,6s)-6-{[méthyl(3,4,5-triméthoxyphényl)amino]méthyl}-1 ,2 ,5 ,6 ,7 ,8 -hexahydro -2 ,4 -quinazolinediamine

Beyond the preview

Go deeper on (2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call